Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

Refractory Septic Shock due to Acute Cholangitis Successfully Treated with Polymyxin B Hemoperfusion: A Case Report

Yasuhiro Ohtsuka and Shin Tsuchiya

A 76-year-old man was transferred to our department because of high fever with chills. According to the Tokyo Guidelines 2018, he was diagnosed with sepsis due to Grade III (severe) acute cholangitis. Fluid resuscitation, noradrenaline administration, antibiotic therapy, and an emergency endoscopic retrograde biliary drainage were
performed. Due to these treatments, his general condition improved initially; however, on the 5th hospital day, he eventually became persistently hypotensive despite adequate fluid resuscitation while on a vasopressor. Under the diagnosis of septic shock, intensive care including endotracheal intubation followed by mechanical ventilation, thoracic drainage, administration of vasopressors, strict antibiotic therapy, and total parenteral nutrition, was promptly initiated; however, he remained in shock. We judged his condition as refractory septic shock that was resistant to conventional treatments. Therefore, endotoxin adsorption therapy with polymyxin B hemoperfusion (PMX-DHP) was attempted on the 7th hospital day, and two sessions of PMX-DHP were carried out 24 h apart. Following this procedure, he successfully recovered from septic shock, and was discharged on the 84th hospital day.
We propose that PMX-DHP might be considered for the treatment of refractory septic shock due to acute cholangitis that is resistant to appropriate conventional treatments, especially when the presence of endotoxemia has been confirmed.